PHASE II MULTICENTRIC AND PROSPECTIVE TRIAL WITH GEMCITABINE AND RAPAMYCIN IN SECOND LINE OF METASTATIC OSTEOSARCOMA [ENSAYO FASE II MULTICENTRICO Y PROSPECTIVO CON GEMCITABINA Y RAPAMICINA EN SEGUNDA LINEA DE OSTEOSARCOMA METASTASICO]

Trial Profile

PHASE II MULTICENTRIC AND PROSPECTIVE TRIAL WITH GEMCITABINE AND RAPAMYCIN IN SECOND LINE OF METASTATIC OSTEOSARCOMA [ENSAYO FASE II MULTICENTRICO Y PROSPECTIVO CON GEMCITABINA Y RAPAMICINA EN SEGUNDA LINEA DE OSTEOSARCOMA METASTASICO]

Recruiting
Phase of Trial: Phase II

Latest Information Update: 26 Sep 2013

At a glance

  • Drugs Gemcitabine (Primary) ; Sirolimus (Primary)
  • Indications Osteosarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top